A new Report by Delvens, titled "Travel Vaccines Market” offers a comprehensive analysis of the industry, which comprises insights on the Global analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The global Travel Vaccines Market size is USD 3.45 billion in 2022 and is projected to reach a CAGR of 11.6% from 2023-2030.
Get Free Sample Report: https://www.delvens.com/get-free-sample/travel-vaccines-market
Travel vaccines also referred to as travel immunizations, are preventative vaccinations against serious diseases that travellers can receive prior to traveling to particular regions of the world. Travel vaccines protect against disease by exposing the body to the microorganism or parts of the microorganism.
The primary factor driving the market growth is the increase in travel and tourism drives, increasing incidence of diseases linked to travel to boost growth, and international Travel Regulations from the Government Over the past few years, there has been a sharp increase in international travel, which has led to a significant increase in the demand for travel vaccines.
Regional Analysis
- Due to rising public health awareness and rising demand for cutting-edge vaccines, the Asia-Pacific region is anticipated to expand at the highest rate between 2023 and 2030. Due to the region's improving healthcare infrastructure and rising government investment in education and awareness programs, it is a booming market for travel vaccines.
- It is anticipated that the market for human immunizations in North America will be dominated by the United States. It is anticipated that the attenuated and recombinant vaccine segments will expand more rapidly than the combination vaccine segments in North America.
Competitive Landscape
- GSK plc (U.K.)
- Sanofi (France)
- Merck KGaA (Germany)
- Novartis AG (Switzerland)
- Pfizer Inc. (U.S.)
- Bavarian Nordic (Denmark)
- Janssen Pharmaceuticals Inc. (U.S.)
- CSL Limited (Australia)
- AstraZeneca (U.K.)
- Altimmune (U.K.)
- Abbott (U.S.)
- Hoffmann-La Roche Ltd (Switzerland)
For More Inquiry Contact us: https://www.delvens.com/Inquire-before-buying/travel-vaccines-market
Recent Developments
In August 2022, Indonesia’s new vaccine for dengue providing a backbone for all four dengue viruses was approved by the authorities for people aged between 6 to 45.
In January 2021, India began its journey toward recovery from a pandemic that has unquestionably disrupted and killed many people by launching the largest vaccination drive.
The travel Vaccines Market is segmented into various segments such as product, application, composition, and region.
On the basis of the application
- Domestic Travel
- Outbound Travel
On the basis of the composition
- Mono Vaccines
- Combination Vaccines
On the basis of product
- Hepatitis A
- DPT
- Yellow Fever
- Typhoid
- Hepatitis B
- Measles and Mumps
- Rabies
- Meningococcal
- Varicella
- Japanese Encephalitis
- Others
Access Full Report: https://www.delvens.com/report/travel-vaccines-market
Frequently Asked Questions
What are the years considered to study this market intelligence report?
The Travel Vaccines Market is studied from 2023-2030.
What is the compound annual growth rate (CAGR) of Travel Vaccines Market?
The Travel Vaccines Market is growing at a CAGR of 11.6% during the forecast period.
Which region holds the largest market share in Travel Vaccines Market?
Asia Pacific holds the highest share during the forecast years.
More Reports from Delvens:
Digital Pharmacy Market size is 96.5 billion USD in 2022 and is projected to reach a CAGR of 18.9% from 2023-2030.
Functional Service Provider (FSP) Market size is projected to reach a CAGR of 8.7% from 2023-2030.
Hormone Replacement Therapy (HRT) Market size is projected to reach a CAGR of 6.3% from 2023-2030.
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT Telecom, Chemicals Materials, Semiconductor Electronics, Energy, Pharmaceutical, Consumer Goods Services, Food Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-3290-6466
+1 214-377-1144
